<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR76">
 <label>76.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chun</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Brinkmann</surname>
    <given-names>V</given-names>
   </name>
  </person-group>
  <article-title>A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya)</article-title>
  <source>Discov Med</source>
  <year>2011</year>
  <volume>12</volume>
  <issue>64</issue>
  <fpage>213</fpage>
  <lpage>228</lpage>
  <?supplied-pmid 21955849?>
  <pub-id pub-id-type="pmid">21955849</pub-id>
 </element-citation>
</ref>
